DIMENSION THERAPEUTICS INC's ticker is DMTX and the CUSIP is 25433V105. A total of 52 filers reported holding DIMENSION THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $44,000 | -59.6% | 25,134 | 0.0% | 0.00% | – |
Q4 2016 | $109,000 | -47.3% | 25,134 | -3.1% | 0.00% | – |
Q3 2016 | $207,000 | +34.4% | 25,934 | +1.2% | 0.00% | – |
Q2 2016 | $154,000 | +63.8% | 25,634 | +113.2% | 0.00% | – |
Q1 2016 | $94,000 | -19.7% | 12,024 | +15.6% | 0.00% | – |
Q4 2015 | $117,000 | – | 10,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,059,283 | $12,356,000 | 10.63% |
RA Capital Management | 1,548,033 | $9,288,000 | 1.29% |
Orbimed Advisors | 5,397,698 | $32,386,000 | 0.34% |
Partner Investment Management, L.P. | 14,761 | $89,000 | 0.15% |
PFM Health Sciences, LP | 666,070 | $3,996,000 | 0.12% |
Rock Springs Capital Management LP | 271,370 | $1,628,000 | 0.12% |
Weiss Multi-Strategy Advisers LLC | 235,549 | $1,413,000 | 0.11% |
Baker Brothers Advisors | 1,251,881 | $7,511,000 | 0.08% |
TFS CAPITAL LLC | 36,741 | $220,000 | 0.04% |
Artal Group S.A. | 275,000 | $1,650,000 | 0.03% |